首页 > 最新文献

Obstetrics and Gynecology International最新文献

英文 中文
Trends of Minimally Invasive Hysterectomy: Five Years of Experience. 微创子宫切除术的发展趋势:五年的经验。
IF 1.6 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-06-12 eCollection Date: 2025-01-01 DOI: 10.1155/ogi/2366445
Abdulrahman Khinkar, Afaf Felemban, Rahaf AlSomali, Norah AlSunayen, Ahmed Felemban, Joud Makki, Ghadeer Aljahdali

Objectives: This study aims to investigate the five-year trend of minimally invasive hysterectomy and identify factors associated with increased intraoperative and postoperative complications within the last five years (2017-2021). Methods: A retrospective chart review was performed between March 30th and April 10th, 2022, which included women who underwent total laparoscopic hysterectomy (TLH), laparoscopic subtotal hysterectomy (LSH), laparoscopic-assisted vaginal hysterectomy (LAVH), and robotic-assisted hysterectomy for benign gynecologic conditions, during the period January 2017 to December 2021. Results: There was an increase in the rate of performing minimally invasive hysterectomy procedures from 35 cases (12.5%) in 2017 to 85 cases (30.5%) in 2021. In addition, abnormal uterine bleeding was the most reported indication for minimally invasive hysterectomy (n = 84; 30.1%). Estimated blood loss was a significant predictor for both intraoperative complications (p < 0.001) and postoperative complications (p=0.004). Conclusion: Within the last five years, there has been an increasing trend of minimally invasive hysterectomy procedures at the OB-GYN department in KAMC, Saudi Arabia. And estimated blood loss is a significant predictor of intraoperative and postoperative complications of minimally invasive hysterectomy.

目的:本研究旨在调查微创子宫切除术的五年趋势,并确定近五年内(2017-2021年)术中术后并发症增加的相关因素。方法:回顾性回顾2022年3月30日至4月10日期间,包括2017年1月至2021年12月期间因妇科良性疾病接受腹腔镜全子宫切除术(TLH)、腹腔镜次全子宫切除术(LSH)、腹腔镜辅助阴道子宫切除术(LAVH)和机器人辅助子宫切除术的女性。结果:微创子宫切除术的发生率从2017年的35例(12.5%)增加到2021年的85例(30.5%)。此外,子宫异常出血是微创子宫切除术报道最多的指征(n = 84;30.1%)。估计失血量是两种术中并发症的重要预测因子(p p=0.004)。结论:近五年来,沙特阿拉伯KAMC妇产科微创子宫切除手术呈上升趋势。估计失血量是微创子宫切除术术中及术后并发症的重要预测指标。
{"title":"Trends of Minimally Invasive Hysterectomy: Five Years of Experience.","authors":"Abdulrahman Khinkar, Afaf Felemban, Rahaf AlSomali, Norah AlSunayen, Ahmed Felemban, Joud Makki, Ghadeer Aljahdali","doi":"10.1155/ogi/2366445","DOIUrl":"10.1155/ogi/2366445","url":null,"abstract":"<p><p><b>Objectives:</b> This study aims to investigate the five-year trend of minimally invasive hysterectomy and identify factors associated with increased intraoperative and postoperative complications within the last five years (2017-2021). <b>Methods:</b> A retrospective chart review was performed between March 30th and April 10th, 2022, which included women who underwent total laparoscopic hysterectomy (TLH), laparoscopic subtotal hysterectomy (LSH), laparoscopic-assisted vaginal hysterectomy (LAVH), and robotic-assisted hysterectomy for benign gynecologic conditions, during the period January 2017 to December 2021. <b>Results:</b> There was an increase in the rate of performing minimally invasive hysterectomy procedures from 35 cases (12.5%) in 2017 to 85 cases (30.5%) in 2021. In addition, abnormal uterine bleeding was the most reported indication for minimally invasive hysterectomy (<i>n</i> = 84; 30.1%). Estimated blood loss was a significant predictor for both intraoperative complications (<i>p</i> < 0.001) and postoperative complications (<i>p</i>=0.004). <b>Conclusion:</b> Within the last five years, there has been an increasing trend of minimally invasive hysterectomy procedures at the OB-GYN department in KAMC, Saudi Arabia. And estimated blood loss is a significant predictor of intraoperative and postoperative complications of minimally invasive hysterectomy.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"2366445"},"PeriodicalIF":1.6,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12178727/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144333573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Awareness, Practice, and Barriers Regarding Cervical Cancer Screening Among Women of Kageshwori Manohara Municipality, Nepal. 尼泊尔Kageshwori Manohara市妇女宫颈癌筛查的认识、实践和障碍。
IF 1.6 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-05-19 eCollection Date: 2025-01-01 DOI: 10.1155/ogi/5325540
Pratima Pathak, Pratima Ghimire, Shyam Kala Chaudhary, Nebina Piya, Nira Shrestha

Background: Cervical cancer remains a global public health concern occurring in most cases in developing countries. Furthermore, it is a highly preventable disease; it remains to be the most common cancer among Nepalese women. Assessing women's awareness of cervical cancer and identifying barriers to screening are of vital importance for the utilization of cervical cancer screening. Therefore, this study has been conducted to assess information regarding awareness, practice, and barriers to cervical cancer screening among the women of Kageshwori Manohara Municipality of Kathmandu district in Nepal. Methods: Community-based descriptive cross-sectional study was conducted among 249 women aged 30-60 years by using a systematic random sampling technique. Data were collected from 1st to 29th February 2024 through a self-constructed semistructured tool using a face-to-face interview technique. Descriptive statistics and the chi-square tests were used for statistical analysis. Results: Out of the total respondents, only 10.4% had adequate awareness regarding cervical cancer screening and 38.6% of the respondents had ever been screened for cervical cancer. Among the respondents who had ever been screened, the majority (86.5%) of their last time screening was within 5 years. A statistically significant association was found between levels of awareness with the age of the respondents (p=0.031), educational level (p=0.013), and number of children (p=0.003). However, no significant association was found with other variables such as age at marriage, ethnicity, occupation, and monthly family income. Absence of symptoms (54.6%), unaware of screening (17.7%), and feeling of embarrassment (11.6%) were the most mentioned barriers to practicing cervical cancer screening among the respondents. Conclusion: The result of this study showed most of the respondents had an inadequate level of awareness and low experience of practicing cervical cancer screening. Therefore, community-based awareness campaigns and screening health camps should be conducted to increase knowledge and practice of cervical cancer screening.

背景:宫颈癌仍然是一个全球公共卫生问题,大多数病例发生在发展中国家。此外,它是一种高度可预防的疾病;它仍然是尼泊尔妇女中最常见的癌症。评估妇女对宫颈癌的认识和确定筛查的障碍对宫颈癌筛查的利用至关重要。因此,本研究旨在评估尼泊尔加德满都地区Kageshwori Manohara市妇女对宫颈癌筛查的认识、实践和障碍。方法:采用系统随机抽样方法,对249名年龄在30 ~ 60岁的社区妇女进行描述性横断面研究。数据采集时间为2024年2月1日至29日,采用自构建半结构化工具,采用面对面访谈技术。采用描述性统计和卡方检验进行统计分析。结果:在所有受访者中,只有10.4%的人对子宫颈癌筛查有足够的认识,38.6%的受访者曾接受过子宫颈癌筛查。在曾经接受过筛查的受访者中,绝大多数(86.5%)的最后一次筛查是在5年内。认知水平与被调查者的年龄(p=0.031)、受教育程度(p=0.013)和子女数量(p=0.003)之间存在统计学上显著的关联。然而,与结婚年龄、种族、职业和家庭月收入等其他变量没有发现显著关联。没有症状(54.6%)、不知道筛查(17.7%)和感到尴尬(11.6%)是受访者进行宫颈癌筛查时提到最多的障碍。结论:本研究结果显示,大多数受访者对宫颈癌筛查的认识水平不足,经验不足。因此,应开展以社区为基础的提高认识运动和筛查保健营,以增加对宫颈癌筛查的认识和实践。
{"title":"Awareness, Practice, and Barriers Regarding Cervical Cancer Screening Among Women of Kageshwori Manohara Municipality, Nepal.","authors":"Pratima Pathak, Pratima Ghimire, Shyam Kala Chaudhary, Nebina Piya, Nira Shrestha","doi":"10.1155/ogi/5325540","DOIUrl":"10.1155/ogi/5325540","url":null,"abstract":"<p><p><b>Background:</b> Cervical cancer remains a global public health concern occurring in most cases in developing countries. Furthermore, it is a highly preventable disease; it remains to be the most common cancer among Nepalese women. Assessing women's awareness of cervical cancer and identifying barriers to screening are of vital importance for the utilization of cervical cancer screening. Therefore, this study has been conducted to assess information regarding awareness, practice, and barriers to cervical cancer screening among the women of Kageshwori Manohara Municipality of Kathmandu district in Nepal. <b>Methods:</b> Community-based descriptive cross-sectional study was conducted among 249 women aged 30-60 years by using a systematic random sampling technique. Data were collected from 1st to 29th February 2024 through a self-constructed semistructured tool using a face-to-face interview technique. Descriptive statistics and the chi-square tests were used for statistical analysis. <b>Results:</b> Out of the total respondents, only 10.4% had adequate awareness regarding cervical cancer screening and 38.6% of the respondents had ever been screened for cervical cancer. Among the respondents who had ever been screened, the majority (86.5%) of their last time screening was within 5 years. A statistically significant association was found between levels of awareness with the age of the respondents (<i>p</i>=0.031), educational level (<i>p</i>=0.013), and number of children (<i>p</i>=0.003). However, no significant association was found with other variables such as age at marriage, ethnicity, occupation, and monthly family income. Absence of symptoms (54.6%), unaware of screening (17.7%), and feeling of embarrassment (11.6%) were the most mentioned barriers to practicing cervical cancer screening among the respondents. <b>Conclusion:</b> The result of this study showed most of the respondents had an inadequate level of awareness and low experience of practicing cervical cancer screening. Therefore, community-based awareness campaigns and screening health camps should be conducted to increase knowledge and practice of cervical cancer screening.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"5325540"},"PeriodicalIF":1.6,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12105882/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144151284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Malnutrition Prevalence and Its Implications on Surgical and Oncological Outcomes in Advanced Ovarian Cancer Patients: A Comprehensive Analysis. 晚期卵巢癌患者营养不良患病率及其对手术和肿瘤预后的影响:一项综合分析。
IF 1.6 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-05-10 eCollection Date: 2025-01-01 DOI: 10.1155/ogi/2918759
Kittithach Pischart, Khemanat Khemworapong, Pattama Chaopotong, Vuthinun Achariyapota

Objective: Malnutrition is a major concern in patients with advanced ovarian cancer, and this condition may be associated with poor treatment outcomes. This study aims to estimate the prevalence of malnutrition in advanced ovarian cancer patients and investigate its impact on both surgical and oncological outcomes. Materials and Methods: This retrospective study included 290 advanced-stage ovarian cancer patients (FIGO stage III-IV) who were not diagnosed with malnutrition. The median follow-up time was 36 months. Malnutrition was defined using the Geriatric Nutritional Risk Index (GNRI). Retrospective data on patient characteristics, treatment complications, and outcomes were recorded. Statistical analyses were performed using IBM SPSS Statistics for Windows (Version 26.0; IBM Corp., Armonk, NY, USA). Results: This study found that 137 of 290 patients (47.2%) had malnutrition. Anemia and chronic kidney disease (CKD) were frequently observed alongside malnutrition. Malnutrition impacts both surgical and oncological outcomes, including the rate of optimal debulking surgeries (35.8% in the malnourished group and 62.7% in the well-nourished group, p < 0.005) and the median length of hospital stay (10 days in the malnourished group and 7 days in the well-nourished group, p < 0.005). Additionally, well-nourished patients had a significant higher overall survival rate (43 months) compared to malnourished patients (30 months). Conclusion: Malnutrition is common among patients with advanced ovarian cancer and is associated with a lower rate of optimal surgery, longer hospital stays, and reduced overall survival rates.

目的:营养不良是晚期卵巢癌患者的一个主要问题,这种情况可能与不良的治疗结果有关。本研究旨在估计晚期卵巢癌患者营养不良的患病率,并探讨其对手术和肿瘤预后的影响。材料与方法:本回顾性研究纳入290例未诊断为营养不良的晚期卵巢癌患者(FIGO III-IV期)。中位随访时间为36个月。营养不良的定义采用老年营养风险指数(GNRI)。记录患者特征、治疗并发症和结果的回顾性数据。采用IBM SPSS Statistics for Windows (Version 26.0;IBM公司,美国纽约州阿蒙克市)。结果:290例患者中有137例(47.2%)存在营养不良。贫血和慢性肾脏疾病(CKD)经常与营养不良一起被观察到。营养不良影响手术和肿瘤预后,包括最佳减重手术率(营养不良组为35.8%,营养良好组为62.7%)。结论:营养不良在晚期卵巢癌患者中很常见,与较低的最佳手术率、较长的住院时间和较低的总生存率相关。
{"title":"Malnutrition Prevalence and Its Implications on Surgical and Oncological Outcomes in Advanced Ovarian Cancer Patients: A Comprehensive Analysis.","authors":"Kittithach Pischart, Khemanat Khemworapong, Pattama Chaopotong, Vuthinun Achariyapota","doi":"10.1155/ogi/2918759","DOIUrl":"10.1155/ogi/2918759","url":null,"abstract":"<p><p><b>Objective:</b> Malnutrition is a major concern in patients with advanced ovarian cancer, and this condition may be associated with poor treatment outcomes. This study aims to estimate the prevalence of malnutrition in advanced ovarian cancer patients and investigate its impact on both surgical and oncological outcomes. <b>Materials and Methods:</b> This retrospective study included 290 advanced-stage ovarian cancer patients (FIGO stage III-IV) who were not diagnosed with malnutrition. The median follow-up time was 36 months. Malnutrition was defined using the Geriatric Nutritional Risk Index (GNRI). Retrospective data on patient characteristics, treatment complications, and outcomes were recorded. Statistical analyses were performed using IBM SPSS Statistics for Windows (Version 26.0; IBM Corp., Armonk, NY, USA). <b>Results:</b> This study found that 137 of 290 patients (47.2%) had malnutrition. Anemia and chronic kidney disease (CKD) were frequently observed alongside malnutrition. Malnutrition impacts both surgical and oncological outcomes, including the rate of optimal debulking surgeries (35.8% in the malnourished group and 62.7% in the well-nourished group, <i>p</i> < 0.005) and the median length of hospital stay (10 days in the malnourished group and 7 days in the well-nourished group, <i>p</i> < 0.005). Additionally, well-nourished patients had a significant higher overall survival rate (43 months) compared to malnourished patients (30 months). <b>Conclusion:</b> Malnutrition is common among patients with advanced ovarian cancer and is associated with a lower rate of optimal surgery, longer hospital stays, and reduced overall survival rates.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"2918759"},"PeriodicalIF":1.6,"publicationDate":"2025-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12085243/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144094480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Innovative Noninvasive HPV Screening Using a Feminine Pad: A Pilot Study for Enhanced Cervical Cancer Detection. 使用女性衬垫的创新无创HPV筛查:一项增强宫颈癌检测的试点研究。
IF 1.6 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-04-28 eCollection Date: 2025-01-01 DOI: 10.1155/ogi/9344596
Rodrigo Aldariz-Amaya, Miriam Rodríguez-Esquivel, Alfonso Ruiz-Romero, Fernanda Anthor, Emmanuel Mares, Angélica Flores-Martínez, Edgar Alejandro Gómez-Villa, Marco Antonio Fuentes-Garcia, Teresa Apresa-García, Ricardo López-Romero, Emmanuel Salcedo, María de Jesús Nambo-Lucio, Mauricio Salcedo

Background: Human papillomavirus (HPV) is a major contributor to cervical cancer (CC), with Papanicolaou (Pap) smears and HPV testing serving as primary screening tools in developed countries. The effectiveness of these methods can vary based on a country's epidemiological and socioeconomic context. This study introduces an innovative, noninvasive method employing surgical gauze worn as a feminine pad for HPV detection, with the aim of simplifying and improving screening processes. Materials and Methods: A total of 184 participants, including individuals classified as healthy, with cervical precursor lesions, or as with confirmed CC, were enrolled. All participants underwent cytological and colposcopic evaluations, with biopsies taken in cases of abnormal results. Each participant wore the device for 8 h, after which DNA was extracted from the soiled devices and analyzed via PCR for mitochondrial and HPV-DNA. Sensitivity and specificity were calculated to assess the effectiveness of HPV detection. Sensitivity and specificity values for HPV detection were obtained. Analysis of diagnostic tests was performed by OpenEpi software. Results: The device was well-received, with high compliance among participants. PCR analysis revealed that 17.7% of healthy, 72.1% of precursor-lesion cases, and 97.1% of CC cases tested positive for HPV. The calculated sensitivity and specificity for detecting high-grade lesions (CIN2+ or CIN2/3 and CC) were 94.81% and 51.28%, respectively. For CC detection, sensitivity was 97.14% with a specificity of 54.39%. Conclusions: The use of this noninvasive device demonstrated a significant correlation with clinical outcomes, supporting its potential as an effective and accessible tool for HPV screening. This method offers a promising alternative to conventional screening techniques, particularly in settings where traditional methods face logistical and socioeconomic challenges.

背景:人乳头瘤病毒(HPV)是宫颈癌(CC)的主要致病因素,在发达国家,巴氏涂片和HPV检测是主要的筛查工具。这些方法的有效性可能因国家的流行病学和社会经济背景而异。本研究介绍了一种创新的、无创的方法,使用手术纱布作为女性衬垫进行HPV检测,目的是简化和改进筛查过程。材料和方法:共纳入184名参与者,包括健康、宫颈前体病变或确诊CC的个体。所有的参与者都接受了细胞学和阴道镜检查,在结果异常的情况下进行了活检。每位参与者佩戴该装置8小时,之后从被污染的装置中提取DNA,并通过PCR分析线粒体和HPV-DNA。计算敏感性和特异性以评估HPV检测的有效性。获得HPV检测的敏感性和特异性值。通过OpenEpi软件对诊断测试进行分析。结果:该装置反响良好,受试者依从性高。PCR分析显示17.7%的健康人、72.1%的前体病变病例和97.1%的CC病例检测出HPV阳性。计算出的检测高级病变(CIN2+或CIN2/3和CC)的灵敏度和特异性分别为94.81%和51.28%。CC检测的敏感性为97.14%,特异性为54.39%。结论:使用这种无创设备与临床结果有显著相关性,支持其作为HPV筛查的有效和可获得的工具的潜力。这种方法为传统筛选技术提供了一种有希望的替代方法,特别是在传统方法面临后勤和社会经济挑战的情况下。
{"title":"Innovative Noninvasive HPV Screening Using a Feminine Pad: A Pilot Study for Enhanced Cervical Cancer Detection.","authors":"Rodrigo Aldariz-Amaya, Miriam Rodríguez-Esquivel, Alfonso Ruiz-Romero, Fernanda Anthor, Emmanuel Mares, Angélica Flores-Martínez, Edgar Alejandro Gómez-Villa, Marco Antonio Fuentes-Garcia, Teresa Apresa-García, Ricardo López-Romero, Emmanuel Salcedo, María de Jesús Nambo-Lucio, Mauricio Salcedo","doi":"10.1155/ogi/9344596","DOIUrl":"https://doi.org/10.1155/ogi/9344596","url":null,"abstract":"<p><p><b>Background:</b> Human papillomavirus (HPV) is a major contributor to cervical cancer (CC), with Papanicolaou (Pap) smears and HPV testing serving as primary screening tools in developed countries. The effectiveness of these methods can vary based on a country's epidemiological and socioeconomic context. This study introduces an innovative, noninvasive method employing surgical gauze worn as a feminine pad for HPV detection, with the aim of simplifying and improving screening processes. <b>Materials and Methods:</b> A total of 184 participants, including individuals classified as healthy, with cervical precursor lesions, or as with confirmed CC, were enrolled. All participants underwent cytological and colposcopic evaluations, with biopsies taken in cases of abnormal results. Each participant wore the device for 8 h, after which DNA was extracted from the soiled devices and analyzed via PCR for mitochondrial and HPV-DNA. Sensitivity and specificity were calculated to assess the effectiveness of HPV detection. Sensitivity and specificity values for HPV detection were obtained. Analysis of diagnostic tests was performed by OpenEpi software. <b>Results:</b> The device was well-received, with high compliance among participants. PCR analysis revealed that 17.7% of healthy, 72.1% of precursor-lesion cases, and 97.1% of CC cases tested positive for HPV. The calculated sensitivity and specificity for detecting high-grade lesions (CIN2+ or CIN2/3 and CC) were 94.81% and 51.28%, respectively. For CC detection, sensitivity was 97.14% with a specificity of 54.39%. <b>Conclusions:</b> The use of this noninvasive device demonstrated a significant correlation with clinical outcomes, supporting its potential as an effective and accessible tool for HPV screening. This method offers a promising alternative to conventional screening techniques, particularly in settings where traditional methods face logistical and socioeconomic challenges.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"9344596"},"PeriodicalIF":1.6,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12052458/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144038303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Study on the Quality of Patient-Centred Endometriosis Mobile Applications: Analysis and Future Prospects. 以患者为中心的子宫内膜异位症移动应用质量研究:分析与未来展望。
IF 1.6 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-04-15 eCollection Date: 2025-01-01 DOI: 10.1155/ogi/5582127
Kevin Dominique Tjandraprawira, Edwin Armawan, Muhammad Alamsyah Aziz, Tono Djuwantono

Introduction: Female technology or 'femtech' is the availability of mobile applications (apps) to monitor specific aspects of women's health. It touts the benefits of technology to empower women with regards to their health, while also allowing close collaboration between patients and physicians. Endometriosis-specific apps is a channel by which female patients discover their endometriosis diagnosis. However, there is currently a paucity of high-quality and evidence-based endometriosis apps. This study assessed the current state and overall quality of such apps. Materials and Methods: This retrospective study assessed patient-centred endometriosis apps on the Apple iTunes Store, in January 2023, excluding certain categories such as conference guidance, gaming, private healthcare, and clinical trial apps. The key term "endometriosis" was used. All patient-centred apps were included. The apps were assessed using the APPLICATIONS scoring system, considering objective factors like pricing, subscriptions, literature references, in-app purchases, connectivity, advertisements, search fields, interoperability, and subjective elements such as navigation ease and presentation. The maximum score is 16 and all applications were assessed in English. Results: Out of the initial 22 apps, 12 (54.5%) were excluded, leaving 10 (45.5%) for analysis. Most apps lacked comprehensiveness, but two apps (LUNA-endometriosis and Frendo) stood out with high scores. These apps incorporated certified scoring systems, provided recommendations for tests and follow-up visits, and offered evidence-based literature on endometriosis. The remaining apps scored poorly, focusing on alternative treatments, healthy diets, or functioning solely as symptom diaries, with limited information on diagnosis and management. Only a few apps allowed booking follow-up visits, and most lacked the capability to export patient-specific data. Few apps measured the likelihood of endometriosis whilst others relied on previous diagnoses. The majority of apps were free, whilst in-app purchases centred around alternative treatments. Overall, the apps were user-friendly, featuring vibrant colours and intuitive interfaces. Conclusions: Only two patient-centred endometriosis apps scored highly in the APPLICATIONS scoring system as they were high-quality, evidence-based and incorporated valid medical recommendations. Other applications scored low as their recommendations lacked quality scientific evidence.

简介:女性科技或“femtech”是指监测女性健康特定方面的移动应用程序的可用性。它大力宣传技术的好处,赋予妇女健康权力,同时也允许患者和医生之间密切合作。子宫内膜异位症专用应用程序是女性患者发现子宫内膜异位症诊断的渠道。然而,目前缺乏高质量和基于证据的子宫内膜异位症应用程序。这项研究评估了这些应用程序的现状和整体质量。材料和方法:本回顾性研究评估了2023年1月苹果iTunes Store上以患者为中心的子宫内膜异位症应用程序,不包括某些类别,如会议指导、游戏、私人医疗保健和临床试验应用程序。使用了关键词“子宫内膜异位症”。包括所有以患者为中心的应用程序。这些应用程序使用应用程序评分系统进行评估,考虑了客观因素,如定价、订阅、文献参考、应用内购买、连接性、广告、搜索字段、互操作性,以及主观因素,如导航易用性和展示。最高分数为16分,所有申请都用英语进行评估。结果:在最初的22个应用程序中,12个(54.5%)被排除,剩下10个(45.5%)用于分析。大多数应用程序缺乏综合性,但两个应用程序(luna -子宫内膜异位症和Frendo)得分很高。这些应用程序结合了经过认证的评分系统,为测试和随访提供建议,并提供有关子宫内膜异位症的循证文献。其余的应用程序得分很低,它们专注于替代疗法、健康饮食,或者仅仅作为症状日记,在诊断和管理方面的信息有限。只有少数应用程序允许预约随访,大多数应用程序缺乏导出患者特定数据的功能。很少有应用程序测量子宫内膜异位症的可能性,而其他应用程序则依赖于以前的诊断。大多数应用都是免费的,而应用内部购买则集中在替代疗法上。总的来说,这些应用程序都是用户友好的,具有鲜艳的色彩和直观的界面。结论:只有两个以患者为中心的子宫内膜异位症应用程序在应用程序评分系统中得分很高,因为它们是高质量的,循证的,并纳入了有效的医疗建议。其他申请得分较低,因为他们的建议缺乏高质量的科学证据。
{"title":"A Study on the Quality of Patient-Centred Endometriosis Mobile Applications: Analysis and Future Prospects.","authors":"Kevin Dominique Tjandraprawira, Edwin Armawan, Muhammad Alamsyah Aziz, Tono Djuwantono","doi":"10.1155/ogi/5582127","DOIUrl":"https://doi.org/10.1155/ogi/5582127","url":null,"abstract":"<p><p><b>Introduction:</b> Female technology or 'femtech' is the availability of mobile applications (apps) to monitor specific aspects of women's health. It touts the benefits of technology to empower women with regards to their health, while also allowing close collaboration between patients and physicians. Endometriosis-specific apps is a channel by which female patients discover their endometriosis diagnosis. However, there is currently a paucity of high-quality and evidence-based endometriosis apps. This study assessed the current state and overall quality of such apps. <b>Materials and Methods:</b> This retrospective study assessed patient-centred endometriosis apps on the Apple iTunes Store, in January 2023, excluding certain categories such as conference guidance, gaming, private healthcare, and clinical trial apps. The key term \"endometriosis\" was used. All patient-centred apps were included. The apps were assessed using the APPLICATIONS scoring system, considering objective factors like pricing, subscriptions, literature references, in-app purchases, connectivity, advertisements, search fields, interoperability, and subjective elements such as navigation ease and presentation. The maximum score is 16 and all applications were assessed in English. <b>Results:</b> Out of the initial 22 apps, 12 (54.5%) were excluded, leaving 10 (45.5%) for analysis. Most apps lacked comprehensiveness, but two apps (LUNA-endometriosis and Frendo) stood out with high scores. These apps incorporated certified scoring systems, provided recommendations for tests and follow-up visits, and offered evidence-based literature on endometriosis. The remaining apps scored poorly, focusing on alternative treatments, healthy diets, or functioning solely as symptom diaries, with limited information on diagnosis and management. Only a few apps allowed booking follow-up visits, and most lacked the capability to export patient-specific data. Few apps measured the likelihood of endometriosis whilst others relied on previous diagnoses. The majority of apps were free, whilst in-app purchases centred around alternative treatments. Overall, the apps were user-friendly, featuring vibrant colours and intuitive interfaces. <b>Conclusions:</b> Only two patient-centred endometriosis apps scored highly in the APPLICATIONS scoring system as they were high-quality, evidence-based and incorporated valid medical recommendations. Other applications scored low as their recommendations lacked quality scientific evidence.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"5582127"},"PeriodicalIF":1.6,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12014267/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144024729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Cross-Sectional Study on Post-COVID-19 Menstrual Abnormalities in Women of Reproductive Age Group at a Tertiary Care Hospital. 某三级医院育龄妇女covid -19后月经异常的横断面研究
IF 1.6 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-03-25 eCollection Date: 2025-01-01 DOI: 10.1155/ogi/1771858
Samyama Sagare Venkatesh, Malathi T, Manasa A S Gowda

Purpose: This study aimed to evaluate the effect of COVID-19 infection and vaccination on all the menstrual cycle parameters in the women of reproductive age group, 18-45 years, at a tertiary care hospital. Methods: A single-center, descriptive cross-sectional study was done from January 2, 2023, to June 24, 2023. Sampling was nonprobabilistic and purposeful. Participants were recruited via calls, in-person interviews, and online surveys. A total of 931 participants were recruited, of which 141 participants were eligible for the study. Descriptive statistics were performed for all variables. Pearson's chi-square test was done to compare categorical variables among different groups, and the Wilcoxon matched pair signed-rank test was done to compare the menstrual cycle patterns before and after COVID-19 infection and vaccination. Simple linear regression and multiple linear regression analysis were done wherever necessary. p < 0.05 was considered statistically significant. Results: A total of 931 participants were recruited, of which 141 participants were eligible for the study. The median age was 29 years. Those who reported menstrual abnormalities were mainly of the age group 18-27 (n = 62, 44.0%), resided in an urban locality (n = 123, 87.2%), and were employed (full-time/part-time) (n = 57, 40.4%). Of the 42 participants with menstrual changes, 27 (64.3%) participants experienced changes post-COVID-19 infection before their first vaccination dose and 15 (35.7%) after the first vaccination dose. In this group, 15 (35.7%) continue to experience abnormalities in their cycles. Analysis showed that participants having severe COVID-19 symptoms were more likely to have an earlier onset of menstrual abnormalities (beta = -2.072, p=0.040). Participants with an above-normal BMI were more likely to have increased pain/cramps during menses (beta = 0.236, p=0.0.013). Participants who were students/employed (beta = -0.365, p=0.001) with an above-normal BMI (beta = 0.182, p=0.024) were more likely to experience increased mood swings/tension/irritability. On comparing the onset and duration of menstrual abnormalities in the post-COVID-19 infection and postvaccination groups, it was found that the latter group had a late-onset and short-term effect, while the former group had an early-onset and long-term effect on menses. Conclusion: Our study shows that there is evidence of the onset of menstrual irregularities following COVID-19 infection and vaccination. The study revealed COVID-19 infection and vaccination influence menstrual cycles, the former posing a higher risk, but their effects on menstruation independent of one another are to be studied further.

目的:本研究旨在评估COVID-19感染和疫苗接种对某三级医院18-45岁育龄妇女所有月经周期参数的影响。方法:从2023年1月2日至2023年6月24日进行了一项单中心、描述性横断面研究。抽样是非概率的和有目的的。参与者是通过电话、面对面访谈和在线调查招募的。总共招募了931名参与者,其中141名参与者符合研究条件。对所有变量进行描述性统计。采用Pearson卡方检验比较不同组间的分类变量,采用Wilcoxon配对对符号秩检验比较感染和接种前后的月经周期模式。必要时进行简单线性回归和多元线性回归分析。P < 0.05为差异有统计学意义。结果:共招募了931名参与者,其中141名参与者符合研究条件。中位年龄为29岁。报告月经异常的患者主要集中在18-27岁年龄段(n = 62, 44.0%),居住在城镇地区(n = 123, 87.2%),工作(n = 57, 40.4%)。在42名有月经变化的参与者中,27名(64.3%)参与者在第一次接种疫苗前经历了covid -19感染后的变化,15名(35.7%)参与者在第一次接种疫苗后经历了变化。在这一组中,15人(35.7%)的月经周期继续出现异常。分析显示,有严重COVID-19症状的参与者更有可能出现更早的月经异常(β = -2.072, p=0.040)。BMI高于正常水平的参与者更有可能在月经期间增加疼痛/痉挛(beta = 0.236, p=0.0.013)。BMI高于正常水平(beta = 0.182, p=0.024)的学生/在职参与者(beta = -0.365, p=0.001)更有可能经历情绪波动/紧张/易怒。对比新冠肺炎感染后和接种疫苗后两组月经异常的发生时间和持续时间,发现接种疫苗后两组对月经异常的影响为晚发性、短期影响,接种疫苗后两组对月经异常的影响为早发性、长期影响。结论:我们的研究表明,有证据表明COVID-19感染和接种疫苗后会出现月经不规律。研究表明,COVID-19感染和疫苗接种会影响月经周期,前者的风险更高,但它们对月经的影响彼此独立,有待进一步研究。
{"title":"A Cross-Sectional Study on Post-COVID-19 Menstrual Abnormalities in Women of Reproductive Age Group at a Tertiary Care Hospital.","authors":"Samyama Sagare Venkatesh, Malathi T, Manasa A S Gowda","doi":"10.1155/ogi/1771858","DOIUrl":"10.1155/ogi/1771858","url":null,"abstract":"<p><p><b>Purpose:</b> This study aimed to evaluate the effect of COVID-19 infection and vaccination on all the menstrual cycle parameters in the women of reproductive age group, 18-45 years, at a tertiary care hospital. <b>Methods:</b> A single-center, descriptive cross-sectional study was done from January 2, 2023, to June 24, 2023. Sampling was nonprobabilistic and purposeful. Participants were recruited via calls, in-person interviews, and online surveys. A total of 931 participants were recruited, of which 141 participants were eligible for the study. Descriptive statistics were performed for all variables. Pearson's chi-square test was done to compare categorical variables among different groups, and the Wilcoxon matched pair signed-rank test was done to compare the menstrual cycle patterns before and after COVID-19 infection and vaccination. Simple linear regression and multiple linear regression analysis were done wherever necessary. <i>p</i> < 0.05 was considered statistically significant. <b>Results:</b> A total of 931 participants were recruited, of which 141 participants were eligible for the study. The median age was 29 years. Those who reported menstrual abnormalities were mainly of the age group 18-27 (<i>n</i> = 62, 44.0%), resided in an urban locality (<i>n</i> = 123, 87.2%), and were employed (full-time/part-time) (<i>n</i> = 57, 40.4%). Of the 42 participants with menstrual changes, 27 (64.3%) participants experienced changes post-COVID-19 infection before their first vaccination dose and 15 (35.7%) after the first vaccination dose. In this group, 15 (35.7%) continue to experience abnormalities in their cycles. Analysis showed that participants having severe COVID-19 symptoms were more likely to have an earlier onset of menstrual abnormalities (beta = -2.072, <i>p</i>=0.040). Participants with an above-normal BMI were more likely to have increased pain/cramps during menses (beta = 0.236, <i>p</i>=0.0.013). Participants who were students/employed (beta = -0.365, <i>p</i>=0.001) with an above-normal BMI (beta = 0.182, <i>p</i>=0.024) were more likely to experience increased mood swings/tension/irritability. On comparing the onset and duration of menstrual abnormalities in the post-COVID-19 infection and postvaccination groups, it was found that the latter group had a late-onset and short-term effect, while the former group had an early-onset and long-term effect on menses. <b>Conclusion:</b> Our study shows that there is evidence of the onset of menstrual irregularities following COVID-19 infection and vaccination. The study revealed COVID-19 infection and vaccination influence menstrual cycles, the former posing a higher risk, but their effects on menstruation independent of one another are to be studied further.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"1771858"},"PeriodicalIF":1.6,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11961280/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143764469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Embryos With "No Result" After PGT-A: A Retrospective Analysis of Causative Factors. PGT-A后胚胎“无结果”:病因的回顾性分析。
IF 1.6 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-03-24 eCollection Date: 2025-01-01 DOI: 10.1155/ogi/4043963
Anastasia Salame, Elias M Dahdouh, Mokhamad Zhaffal, Rania Aljafari, Arya Muraleekrishnan, Aparna Bajpai, Shabin Kainoth, Leyla Depret Bixio, Michael Fakih

Background: "No result" after PGT-A is a rare observation. Factors suspected to cause inconclusive diagnoses include poor embryo quality, day of biopsy, biopsy technique, and technical amplification failure due to diluted DNA material. This study aimed to highlight the predisposing factors that could lead to a "no result" observation after PGT-A. Results: This is a retrospective cohort study involving 177 patients and 1335 blastocysts, 1242 of which comprised the control (result) group and 93 comprised the study (no result) group. The predisposing factors studied were the number of blastocysts available for biopsy, the day of biopsy, the grade of the embryo, the degree of expansion of the blastocyst, and the grade of the trophectoderm on biopsy day. The rate of "no result" embryos did not depend on the degree of expansion of the embryo, the trophectoderm quality, the day of biopsy, or embryo grade (p=0.139, 0.34, 0.332, and 0.272, respectively). Regression analysis showed that the studied embryo characteristics were not significant predisposing factors. However, having more blastocysts to biopsy per patient was found to be a significant predictor of "no result" embryos. Conclusion: No clear embryo-related risk factors could be elucidated; however, the biopsy procedure and sample cellularity seem to be crucial components. In addition, having more embryos per patient to biopsy at a given time might increase the risk of having inconclusive biopsy results.

背景:PGT-A后“无结果”是一种罕见的观察。怀疑导致不确定诊断的因素包括胚胎质量差、活检日期、活检技术以及由于DNA材料稀释导致的技术扩增失败。本研究旨在强调可能导致PGT-A后“无结果”观察的易感因素。结果:这是一项回顾性队列研究,涉及177例患者和1335个囊胚,其中1242个为对照(结果)组,93个为研究(无结果)组。研究的易感因素是可用于活检的囊胚数量、活检日期、胚胎的分级、囊胚的扩张程度和活检当天的滋养外胚层分级。“无结果”胚胎的比率与胚胎的膨胀程度、滋养外胚层质量、活检天数或胚胎等级无关(p分别=0.139、0.34、0.332和0.272)。回归分析表明,所研究的胚胎性状不是显著的易感因素。然而,每个患者有更多的囊胚活检被发现是“无结果”胚胎的重要预测因子。结论:没有明确的胚胎相关危险因素;然而,活检程序和样本细胞结构似乎是至关重要的组成部分。此外,在给定时间内,每个患者有更多的胚胎进行活检可能会增加活检结果不确定的风险。
{"title":"Embryos With \"No Result\" After PGT-A: A Retrospective Analysis of Causative Factors.","authors":"Anastasia Salame, Elias M Dahdouh, Mokhamad Zhaffal, Rania Aljafari, Arya Muraleekrishnan, Aparna Bajpai, Shabin Kainoth, Leyla Depret Bixio, Michael Fakih","doi":"10.1155/ogi/4043963","DOIUrl":"10.1155/ogi/4043963","url":null,"abstract":"<p><p><b>Background:</b> \"No result\" after PGT-A is a rare observation. Factors suspected to cause inconclusive diagnoses include poor embryo quality, day of biopsy, biopsy technique, and technical amplification failure due to diluted DNA material. This study aimed to highlight the predisposing factors that could lead to a \"no result\" observation after PGT-A. <b>Results:</b> This is a retrospective cohort study involving 177 patients and 1335 blastocysts, 1242 of which comprised the control (result) group and 93 comprised the study (no result) group. The predisposing factors studied were the number of blastocysts available for biopsy, the day of biopsy, the grade of the embryo, the degree of expansion of the blastocyst, and the grade of the trophectoderm on biopsy day. The rate of \"no result\" embryos did not depend on the degree of expansion of the embryo, the trophectoderm quality, the day of biopsy, or embryo grade (<i>p</i>=0.139, 0.34, 0.332, and 0.272, respectively). Regression analysis showed that the studied embryo characteristics were not significant predisposing factors. However, having more blastocysts to biopsy per patient was found to be a significant predictor of \"no result\" embryos. <b>Conclusion:</b> No clear embryo-related risk factors could be elucidated; however, the biopsy procedure and sample cellularity seem to be crucial components. In addition, having more embryos per patient to biopsy at a given time might increase the risk of having inconclusive biopsy results.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"4043963"},"PeriodicalIF":1.6,"publicationDate":"2025-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11957852/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143753654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Clinical Pathological Characteristics and Prognostic Relevance of Homologous Recombination Repair Gene Mutations in Ovarian Cancer Patients: A Prospective Cohort Study. 卵巢癌患者同源重组修复基因突变的临床病理特征和预后相关性:一项前瞻性队列研究。
IF 1.6 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-03-24 eCollection Date: 2025-01-01 DOI: 10.1155/ogi/5578247
Shitong Zhan, Feng Chen, Lijuan Huang, Lin Chen, Haoyi Jia, Shaofei Ma, Min Tang, Chongzhi Zhou, Yanmin Chen, Ye Yang
<p><p><b>Backgrouds:</b> Whether homologous recombination repair (HRR) mutation has a differential effect on the prognosis has not been confirmed by current studies. The purpose of this study was to explore the clinical importance, prognostic value, and frequency of pathogenic changes in HRR genes in patients with ovarian cancer (OC). <b>Methods:</b> We analyze information including HRR mutation and clinical prognosis of OC patients both in our cohort and in the TCGA-OV database. Blood and/or tumor samples from 98 women admitted to Shanghai General Hospital between January 2021 and May 2024, and DNA sequencing was performed on these samples for all patients included in this retrospective study. Testing was performed for HRR mutations, including germline BRCA1/2 mutations, and defects in HRR were defined as detrimental mutations within relevant genes. Comprehensive medical records were gathered for all patients, with a follow-up period recorded for 74 of them. <b>Results:</b> HRR pathway genes, including BRCA1/2, CDK12, RAD54L, RAD51, ATM, MRE11, and BRIP2, are highly expressed in FIGO Stages I-II OCs among 482 patients in the TCGA-OV database, and 95.06% samples presented mutations. The alignment diagram analyzed by logistic and Cox regression was derived to investigate HRR genes on overall survival (OS < 763 days) of OC patients. A total of 98 patients were enrolled in our study, with 70 harboring HRR mutations (HRRmt) and 28 having the HRR wild-type (HRRwt). The predominant pathological type across all four patient groups was high-grade serous adenocarcinoma, with similar prevalence in HRRmt (84.30%) versus HRRwt (75%, <i>p</i>=0.360) and BRCAmt (94.20%) versus BRCAwt (74.60%, <i>p</i>=0.151) groups. Survival prediction data were collected from 74 patients, and the HRRmt group (<i>n</i> = 50) exhibited a numerically longer PFS compared to the HRRwt group (<i>n</i> = 24), with 23 months versus 17 months, respectively. A significant disparity was noted in the percentage of patients administered PARPi medication between the HRRmt and HRRwt groups (58.00% vs. 20.20%; <i>p</i>=0.003). Patients in both the HRRmt group (<i>p</i>=0.049) and the BRCAwt group (<i>p</i>=0.046) receiving PARPi treatment have extended PFS. Significant differences were identified between HRRmt and HRRwt groups in the size of the initial debulking surgery achieving R0 status (<i>p</i>=0.005), low CA125 levels (< 1000 U/mL) at diagnosis (<i>p</i>=0.015), and the use of PARP inhibitors (PARPi) (<i>p</i>=0.024) and antiangiogenic drugs (<i>p</i> < 0.001). For patients with HRR mutations, the use of PARPi significantly impacted PFS (<i>p</i>=0.049), and achieving R0 status (<i>p</i>=0.005) significantly influenced PFS. <b>Conclusions:</b> This study indicates that mutations in the HRR gene possess significant potential as a prognostic marker in OC. Our aim was to comprehensively explore how HRR gene mutations, including but not limited to BRCA, might influence the clinical course
背景:同源重组修复(homologous recombination repair, HRR)突变是否对预后有差异影响,目前的研究尚未证实。本研究的目的是探讨卵巢癌(OC)患者HRR基因致病性改变的临床意义、预后价值和频率。方法:我们分析本队列和TCGA-OV数据库中OC患者的HRR突变和临床预后信息。我们收集了2021年1月至2024年5月期间上海总医院收治的98名女性患者的血液和/或肿瘤样本,并对本回顾性研究中所有患者的这些样本进行了DNA测序。对HRR突变进行检测,包括种系BRCA1/2突变,并将HRR缺陷定义为相关基因中的有害突变。收集了所有患者的综合医疗记录,并记录了其中74名患者的随访期。结果:在TCGA-OV数据库的482例FIGO I-II期OCs中,HRR通路基因BRCA1/2、CDK12、RAD54L、RAD51、ATM、MRE11、BRIP2高表达,其中95.06%的样本出现突变。通过logistic和Cox回归分析得出比对图,研究HRR基因对总生存率(OS p=0.360)和BRCAmt组(94.20%)与brcat组(74.60%,p=0.151)的影响。从74名患者中收集了生存预测数据,HRRmt组(n = 50)比HRRwt组(n = 24)表现出更长的PFS,分别为23个月和17个月。HRRmt组和HRRwt组接受PARPi治疗的患者比例存在显著差异(58.00% vs 20.20%;p = 0.003)。HRRmt组(p=0.049)和BRCAwt组(p=0.046)接受PARPi治疗的患者均延长了PFS。HRRmt组和HRRwt组在达到R0状态的初始减容手术的大小(p=0.005)、诊断时低CA125水平(< 1000 U/mL) (p=0.015)、PARP抑制剂(PARPi) (p=0.024)和抗血管生成药物(p < 0.001)的使用方面存在显著差异。对于HRR突变患者,使用PARPi显著影响PFS (p=0.049),达到R0状态(p=0.005)显著影响PFS。结论:本研究表明,HRR基因突变具有作为OC预后标志物的重要潜力。我们的目的是全面探索HRR基因突变(包括但不限于BRCA)如何影响患者的临床病程和生存,揭示个性化治疗策略的潜在新途径。
{"title":"The Clinical Pathological Characteristics and Prognostic Relevance of Homologous Recombination Repair Gene Mutations in Ovarian Cancer Patients: A Prospective Cohort Study.","authors":"Shitong Zhan, Feng Chen, Lijuan Huang, Lin Chen, Haoyi Jia, Shaofei Ma, Min Tang, Chongzhi Zhou, Yanmin Chen, Ye Yang","doi":"10.1155/ogi/5578247","DOIUrl":"10.1155/ogi/5578247","url":null,"abstract":"&lt;p&gt;&lt;p&gt;&lt;b&gt;Backgrouds:&lt;/b&gt; Whether homologous recombination repair (HRR) mutation has a differential effect on the prognosis has not been confirmed by current studies. The purpose of this study was to explore the clinical importance, prognostic value, and frequency of pathogenic changes in HRR genes in patients with ovarian cancer (OC). &lt;b&gt;Methods:&lt;/b&gt; We analyze information including HRR mutation and clinical prognosis of OC patients both in our cohort and in the TCGA-OV database. Blood and/or tumor samples from 98 women admitted to Shanghai General Hospital between January 2021 and May 2024, and DNA sequencing was performed on these samples for all patients included in this retrospective study. Testing was performed for HRR mutations, including germline BRCA1/2 mutations, and defects in HRR were defined as detrimental mutations within relevant genes. Comprehensive medical records were gathered for all patients, with a follow-up period recorded for 74 of them. &lt;b&gt;Results:&lt;/b&gt; HRR pathway genes, including BRCA1/2, CDK12, RAD54L, RAD51, ATM, MRE11, and BRIP2, are highly expressed in FIGO Stages I-II OCs among 482 patients in the TCGA-OV database, and 95.06% samples presented mutations. The alignment diagram analyzed by logistic and Cox regression was derived to investigate HRR genes on overall survival (OS &lt; 763 days) of OC patients. A total of 98 patients were enrolled in our study, with 70 harboring HRR mutations (HRRmt) and 28 having the HRR wild-type (HRRwt). The predominant pathological type across all four patient groups was high-grade serous adenocarcinoma, with similar prevalence in HRRmt (84.30%) versus HRRwt (75%, &lt;i&gt;p&lt;/i&gt;=0.360) and BRCAmt (94.20%) versus BRCAwt (74.60%, &lt;i&gt;p&lt;/i&gt;=0.151) groups. Survival prediction data were collected from 74 patients, and the HRRmt group (&lt;i&gt;n&lt;/i&gt; = 50) exhibited a numerically longer PFS compared to the HRRwt group (&lt;i&gt;n&lt;/i&gt; = 24), with 23 months versus 17 months, respectively. A significant disparity was noted in the percentage of patients administered PARPi medication between the HRRmt and HRRwt groups (58.00% vs. 20.20%; &lt;i&gt;p&lt;/i&gt;=0.003). Patients in both the HRRmt group (&lt;i&gt;p&lt;/i&gt;=0.049) and the BRCAwt group (&lt;i&gt;p&lt;/i&gt;=0.046) receiving PARPi treatment have extended PFS. Significant differences were identified between HRRmt and HRRwt groups in the size of the initial debulking surgery achieving R0 status (&lt;i&gt;p&lt;/i&gt;=0.005), low CA125 levels (&lt; 1000 U/mL) at diagnosis (&lt;i&gt;p&lt;/i&gt;=0.015), and the use of PARP inhibitors (PARPi) (&lt;i&gt;p&lt;/i&gt;=0.024) and antiangiogenic drugs (&lt;i&gt;p&lt;/i&gt; &lt; 0.001). For patients with HRR mutations, the use of PARPi significantly impacted PFS (&lt;i&gt;p&lt;/i&gt;=0.049), and achieving R0 status (&lt;i&gt;p&lt;/i&gt;=0.005) significantly influenced PFS. &lt;b&gt;Conclusions:&lt;/b&gt; This study indicates that mutations in the HRR gene possess significant potential as a prognostic marker in OC. Our aim was to comprehensively explore how HRR gene mutations, including but not limited to BRCA, might influence the clinical course","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"5578247"},"PeriodicalIF":1.6,"publicationDate":"2025-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11957853/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143753655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Women's Awareness and Knowledge of Planned Oocyte Cryopreservation at Different Sociocultural Levels: A Cross-Sectional Survey. 评价不同社会文化水平女性对计划卵母细胞冷冻保存的认识和知识:一项横断面调查。
IF 1.6 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-03-03 eCollection Date: 2025-01-01 DOI: 10.1155/ogi/8491436
Sara Salihi, Fatma Başak Tanoğlu, Ali Gökçe, Hikmet Tunç Timur, Özge Pasin, Pınar Özcan

Objective: This study evaluated awareness and knowledge of planned oocyte cryopreservation (POC) among Turkish women across diverse sociocultural backgrounds. Design: This is a cross-sectional survey with a 56-item self-administered electronic questionnaire. Setting: Istanbul, Turkiye, June to September 2022. Population: The study evaluated 915 participants between 21 and 45 years. Methods: Women completed a 56-item self-administered online electronic questionnaire survey to identify their demographic information, perspective on family planning, future fertility expectations/plans, oocyte freezing, and degree of knowledge. Main Outcome Measures: Comparison of participants considering and not considering POC. Results: A total of 464 (50.7%) women indicated an intent to undergo POC in the future, with statistically significantly higher university graduates in the group clearly considering POC (p=0.044) and a higher rate of singles indicating an intent to POC. A total of 546 (59.7%) women planned to have children in the future; the participants considered the age of 39.37 (±5.01) as "old" for pregnancy; 748 (81.7%) of the participants thought that the information about age-related fertility decline and POC should be a part of the annual gynecological examination. The level of knowledge about family planning/postponing fertility and POC between the two groups showed that the group considering POC provided significantly more accurate responses to seven items (5th, 6th, 7th, 10th, 11th, 14th, and 17th questions). The group not considering POC answered correctly, "What is the rate of spontaneous female conception?" (p=0.047). Conclusion: The target population expected to benefit from POC in our country had low knowledge and awareness of age-related fertility decline and POC. Most women expected the information to be a part of the annual gynecological examination. The main determinants of the knowledge score and considering POC are education level and relationship status.

目的:本研究评估了不同社会文化背景的土耳其妇女对计划卵母细胞冷冻保存(POC)的认识和知识。设计:这是一项横断面调查,有56项自我管理的电子问卷。地点:土耳其伊斯坦布尔,2022年6月至9月。人口:该研究评估了915名年龄在21至45岁之间的参与者。方法:妇女完成56项自我管理的在线电子问卷调查,以确定其人口统计信息、对计划生育的看法、未来生育预期/计划、卵母细胞冷冻和知识程度。主要结局指标:考虑和未考虑POC的参与者的比较。结果:共有464名(50.7%)女性表示有意在未来进行POC,在明确考虑POC的组中,有统计学意义的大学毕业生比例更高(p=0.044),单身人士比例更高(p=0.044)。546名(59.7%)妇女计划将来要孩子;参与者认为39.37(±5.01)岁为怀孕“高龄”;748人(81.7%)认为应在妇科年度检查中纳入与年龄有关的生育能力下降和POC信息。两组间关于计划生育/推迟生育和POC的知识水平显示,考虑POC的组对第5、6、7、10、11、14、17个问题的回答准确率显著高于考虑POC的组。不考虑不孕不育的一组正确回答了“女性自然受孕率是多少?”(p = 0.047)。结论:我国预期受益于POC的目标人群对年龄相关性生育率下降和POC的认知和意识较低。大多数女性希望这些信息成为年度妇科检查的一部分。知识得分和考虑POC的主要决定因素是教育水平和关系状况。
{"title":"Evaluation of Women's Awareness and Knowledge of Planned Oocyte Cryopreservation at Different Sociocultural Levels: A Cross-Sectional Survey.","authors":"Sara Salihi, Fatma Başak Tanoğlu, Ali Gökçe, Hikmet Tunç Timur, Özge Pasin, Pınar Özcan","doi":"10.1155/ogi/8491436","DOIUrl":"https://doi.org/10.1155/ogi/8491436","url":null,"abstract":"<p><p><b>Objective:</b> This study evaluated awareness and knowledge of planned oocyte cryopreservation (POC) among Turkish women across diverse sociocultural backgrounds. <b>Design:</b> This is a cross-sectional survey with a 56-item self-administered electronic questionnaire. <b>Setting:</b> Istanbul, Turkiye, June to September 2022. <b>Population:</b> The study evaluated 915 participants between 21 and 45 years. <b>Methods:</b> Women completed a 56-item self-administered online electronic questionnaire survey to identify their demographic information, perspective on family planning, future fertility expectations/plans, oocyte freezing, and degree of knowledge. <b>Main Outcome Measures:</b> Comparison of participants considering and not considering POC. <b>Results:</b> A total of 464 (50.7%) women indicated an intent to undergo POC in the future, with statistically significantly higher university graduates in the group clearly considering POC (<i>p</i>=0.044) and a higher rate of singles indicating an intent to POC. A total of 546 (59.7%) women planned to have children in the future; the participants considered the age of 39.37 (±5.01) as \"old\" for pregnancy; 748 (81.7%) of the participants thought that the information about age-related fertility decline and POC should be a part of the annual gynecological examination. The level of knowledge about family planning/postponing fertility and POC between the two groups showed that the group considering POC provided significantly more accurate responses to seven items (5th, 6th, 7th, 10th, 11th, 14th, and 17th questions). The group not considering POC answered correctly, \"What is the rate of spontaneous female conception?\" (<i>p</i>=0.047). <b>Conclusion:</b> The target population expected to benefit from POC in our country had low knowledge and awareness of age-related fertility decline and POC. Most women expected the information to be a part of the annual gynecological examination. The main determinants of the knowledge score and considering POC are education level and relationship status.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"8491436"},"PeriodicalIF":1.6,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11991840/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144030307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of Intrapartum Perineal Massage in Preventing Perineal Trauma in Nulliparous Women During the Second Stage of Labour: A Randomised Controlled Trial. 一项随机对照试验:产时会阴按摩预防第二产程未产妇女会阴创伤的有效性。
IF 1.6 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-02-28 eCollection Date: 2025-01-01 DOI: 10.1155/ogi/1866988
Obinna K Nnabuchi, George U Eleje, Joseph I Adinma, Emmanuel O Ugwu, Ahizechukwu C Eke, Joseph I Ikechebelu, Okechukwu C Ikpeze, Betrand O Nwosu, Gerald O Udigwe, Joseph O Ugboaja, Osita S Umeononihu, Chukwudi A Ogabido, Ikechukwu I Mbachu, Chukwuemeka O Ezeama, Richard O Egeonu, Arinze C Ikeotuonye, Tobechi K Njoku, Chukwuemeka C Okoro, Charlotte B Oguejiofor, Ifeanyichukwu J Ofor, Ifeoma M Nnabuchi, Chidinma C Okafor, Chinedu L Olisa, Chigozie G Okafor

Objectives: To determine the effectiveness of perineal massage during the second stage of labour in preventing perineal trauma in nulliparous women. Methods: A randomized control trial involving 104 nulliparous women undergoing vaginal delivery. The participants were randomised into two arms (intervention-group 'A' and control-group 'B') in a 1:1 ratio. The intervention group had perineal massage and routine hands-on technique according to the hospital protocol while the control group received only hands-on technique. The primary outcome measure was the incidence of perineal tears during vaginal delivery, while the secondary outcome measures were the incidence of episiotomy during vaginal delivery, the mean duration of second stage of labour, and perineal pain score. Results: The baseline socio-demographic and maternal characteristics of the participants were similar in both arms. The incidence of perineal lacerations in the intervention group (massage group) was significantly lower than in the control group (27 (54%) vs. 40 (81.6%); p=0.003). Although the incidence of episiotomy (26% vs. 44.9%; RR = 0.66; 95% CI = 0.50-0.88; p=0.060) was not significantly different, mean perineal pain score at 4 h postpartum (4.3 ± 0.3 vs. 6.1 ± 0.50; p=0.03), mean perineal pain score at 24 h postpartum (2.2 ± 0.1 vs. 4.2 ± 0.3; p=0.02), and mean duration of second stage of labour (83.1 ± 17.5 min vs. 94.2 ± 18.9 min; p=0.002) were significantly lower in the intervention-group. There was no significant difference in the neonatal outcomes (head circumference, birth weight, and Apgar scores: p > 0.05) between the two groups. Conclusion: Intrapartum perineal massage significantly decreases the risk of overall perineal trauma, perineal pain, and duration of the second stage of labour among nulliparous parturients during the second stage of labour. Nulliparous women should be counselled on the potential benefits of intrapartum perineal massage, and obstetricians are encouraged to provide the technique to consenting women. Trial Registration: Pan African Clinical Trial Registry (PACTR): PACTR 202207835155214.

目的:探讨产程第二阶段会阴按摩对预防无产妇女会阴创伤的效果。方法:采用随机对照试验,纳入104例阴道分娩的无产妇女。参与者按1:1的比例随机分为两组(干预组“A”和对照组“B”)。干预组按医院方案进行会阴按摩及常规手法治疗,对照组仅进行手法治疗。主要指标是阴道分娩时会阴撕裂的发生率,而次要指标是阴道分娩时会阴切开术的发生率、第二产程的平均持续时间和会阴疼痛评分。结果:两组参与者的基线社会人口统计学和母亲特征相似。干预组(按摩组)会阴撕裂伤发生率明显低于对照组(27例(54%)∶40例(81.6%);p = 0.003)。虽然外阴切开术的发生率(26% vs. 44.9%;rr = 0.66;95% ci = 0.50-0.88;P =0.060)差异无统计学意义,产后4 h会阴疼痛平均评分(4.3±0.3∶6.1±0.50;P =0.03),产后24 h会阴疼痛平均评分(2.2±0.1∶4.2±0.3;P =0.02),第二产程平均持续时间(83.1±17.5 min vs 94.2±18.9 min);P =0.002)显著低于干预组。两组新生儿结局(头围、出生体重、Apgar评分:p < 0.05)无显著差异。结论:产时会阴按摩可显著降低二产程产妇会阴整体创伤、会阴疼痛及二产程持续时间。未产妇女应被告知产时会阴按摩的潜在好处,并鼓励产科医生向同意的妇女提供这项技术。试验注册:泛非临床试验注册中心(PACTR): PACTR 202207835155214。
{"title":"Effectiveness of Intrapartum Perineal Massage in Preventing Perineal Trauma in Nulliparous Women During the Second Stage of Labour: A Randomised Controlled Trial.","authors":"Obinna K Nnabuchi, George U Eleje, Joseph I Adinma, Emmanuel O Ugwu, Ahizechukwu C Eke, Joseph I Ikechebelu, Okechukwu C Ikpeze, Betrand O Nwosu, Gerald O Udigwe, Joseph O Ugboaja, Osita S Umeononihu, Chukwudi A Ogabido, Ikechukwu I Mbachu, Chukwuemeka O Ezeama, Richard O Egeonu, Arinze C Ikeotuonye, Tobechi K Njoku, Chukwuemeka C Okoro, Charlotte B Oguejiofor, Ifeanyichukwu J Ofor, Ifeoma M Nnabuchi, Chidinma C Okafor, Chinedu L Olisa, Chigozie G Okafor","doi":"10.1155/ogi/1866988","DOIUrl":"https://doi.org/10.1155/ogi/1866988","url":null,"abstract":"<p><p><b>Objectives:</b> To determine the effectiveness of perineal massage during the second stage of labour in preventing perineal trauma in nulliparous women. <b>Methods:</b> A randomized control trial involving 104 nulliparous women undergoing vaginal delivery. The participants were randomised into two arms (intervention-group 'A' and control-group 'B') in a 1:1 ratio. The intervention group had perineal massage and routine hands-on technique according to the hospital protocol while the control group received only hands-on technique. The primary outcome measure was the incidence of perineal tears during vaginal delivery, while the secondary outcome measures were the incidence of episiotomy during vaginal delivery, the mean duration of second stage of labour, and perineal pain score. <b>Results:</b> The baseline socio-demographic and maternal characteristics of the participants were similar in both arms. The incidence of perineal lacerations in the intervention group (massage group) was significantly lower than in the control group (27 (54%) vs. 40 (81.6%); <i>p</i>=0.003). Although the incidence of episiotomy (26% vs. 44.9%; RR = 0.66; 95% CI = 0.50-0.88; <i>p</i>=0.060) was not significantly different, mean perineal pain score at 4 h postpartum (4.3 ± 0.3 vs. 6.1 ± 0.50; <i>p</i>=0.03), mean perineal pain score at 24 h postpartum (2.2 ± 0.1 vs. 4.2 ± 0.3; <i>p</i>=0.02), and mean duration of second stage of labour (83.1 ± 17.5 min vs. 94.2 ± 18.9 min; <i>p</i>=0.002) were significantly lower in the intervention-group. There was no significant difference in the neonatal outcomes (head circumference, birth weight, and Apgar scores: <i>p</i> > 0.05) between the two groups. <b>Conclusion:</b> Intrapartum perineal massage significantly decreases the risk of overall perineal trauma, perineal pain, and duration of the second stage of labour among nulliparous parturients during the second stage of labour. Nulliparous women should be counselled on the potential benefits of intrapartum perineal massage, and obstetricians are encouraged to provide the technique to consenting women. <b>Trial Registration:</b> Pan African Clinical Trial Registry (PACTR): PACTR 202207835155214.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"1866988"},"PeriodicalIF":1.6,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11991778/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143984499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Obstetrics and Gynecology International
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1